We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
(-3%)
Cap. Flow
+$5.74B
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$423M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$367M |
| 3 |
ExxonMobil
XOM
|
+$337M |
| 4 |
Johnson & Johnson
JNJ
|
+$257M |
| 5 |
Biogen
BIIB
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$195M |
| 2 |
AbbVie
ABBV
|
+$188M |
| 3 |
JPMorgan Chase
JPM
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$176M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.49% |
| 2 | Financials | 16.75% |
| 3 | Technology | 9.99% |
| 4 | Industrials | 8.32% |
| 5 | Energy | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Universal Corp
UVV
$1.37B
| $704K | ﹤0.01% |
14,195
-500
| -3% | -$26.3K |
|
1927
MaxLinear
MXL
$5.19B
| $702K | ﹤0.01% |
56,395
-1,356
| -2% | -$14.9K |
|
|
DOC
1928
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $702K | ﹤0.01% |
46,511
-318
| -0.7% | -$4.89K |
|
|
BNCL
1929
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $700K | ﹤0.01% |
52,754
+5,535
| +12% | +$70.9K |
|
1930
Sturm, Ruger & Co
RGR
$603M
| $698K | ﹤0.01% |
11,891
-624
| -5% | -$37.4K |
|
|
WMGI
1931
DELISTED
Wright Medical Group Inc
WMGI
| $697K | ﹤0.01% |
33,171
-775
| -2% | -$19.3K |
|
1932
CALL
ProShares Short VIX Short-Term Futures ETF
SVXY
$217M
| $696K | ﹤0.01% |
14,600
+8,600
| +143% | +$625K |
|
|
AL
1933
DELISTED
Air Lease Corp
AL
| $695K | ﹤0.01% |
22,465
+8,406
| +60% | +$280K |
|
1934
Watsco Inc
WSO
$13.2B
| $693K | ﹤0.01% |
5,849
+1,875
| +47% | +$234K |
|
|
ENZN
1935
DELISTED
ENZON PHARMACEUTICALS INC
ENZN
| $693K | ﹤0.01% |
714,323
-31,937
| -4% | -$39.3K |
|
|
VG
1936
DELISTED
Vonage Holdings Corporation
VG
| $692K | ﹤0.01% |
117,723
-2,928
| -2% | -$16.6K |
|
1937
Werner Enterprises
WERN
$2.2B
| $691K | ﹤0.01% |
27,529
-997
| -3% | -$27.2K |
|
1938
IDT Corp
IDT
$1.67B
| $690K | ﹤0.01% |
68,304
-11,652
| -15% | -$134K |
|
|
DNY
1939
DELISTED
DONNELLEY R R & SONS CO
DNY
| $690K | ﹤0.01% |
47,384
+15,941
| +51% | +$232K |
|
1940
Atlantic Union Bankshares
AUB
$6.05B
| $689K | ﹤0.01% |
28,693
-681
| -2% | -$16.2K |
|
1941
Advanced Micro Devices
AMD
$700B
| $688K | ﹤0.01% |
400,249
-13,708
| -3% | -$25.8K |
|
1942
Hawaiian Electric Industries
HE
$2.26B
| $685K | ﹤0.01% |
23,860
+8,854
| +59% | +$260K |
|
1943
Paycom
PAYC
$7.88B
| $684K | ﹤0.01% |
19,054
-9,315
| -33% | -$338K |
|
|
DTLK
1944
DELISTED
Datalink Corp
DTLK
| $684K | ﹤0.01% |
114,499
+100,088
| +695% | +$650K |
|
|
SAFE
1945
Safehold
SAFE
$1.17B
| $683K | ﹤0.01% |
11,157
-143
| -1% | -$8.96K |
|
1946
Advanced Energy
AEIS
$10.1B
| $682K | ﹤0.01% |
25,950
-693
| -3% | -$17.9K |
|
1947
Vaalco Energy
EGY
$562M
| $682K | ﹤0.01% |
401,361
-1,893
| -0.5% | -$3.11K |
|
|
PGRE
1948
DELISTED
Paramount Group
PGRE
| $682K | ﹤0.01% |
40,573
+18,755
| +86% | +$324K |
|
|
JOY
1949
DELISTED
Joy Global Inc
JOY
| $682K | ﹤0.01% |
45,652
+44,603
| +4,252% | +$1.08M |
|
1950
SiriusPoint
SPNT
$3.03B
| $679K | ﹤0.01% |
50,495
-730
| -1% | -$10.4K |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.
- BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
- BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
- BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
- BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
- BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
- BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
- BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.
Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.